WAI CHUN BIOTEC (00660) Announces Annual Results, Profit Attributable to Shareholders HK$7.205 million, Trading Resumes on November 16

WAI CHUN BIOTEC (00660) announced its annual results for the year ended June 30, 2026, with revenue of HK$405 million, up 7.3% year-on-year; profit attributable to owners of the company of HK$7.205 million, compared with a loss of HK$14.623 million in the same period last year; basic earnings per share of 3.40 HK cents. The turnaround from loss to profit during the period was mainly due to the reversal of impairment losses on property, plant and equipment in the current year. The increase in revenue was mainly driven by an increase in customers and orders during the year. In addition, the company has applied to the Stock Exchange for the resumption of trading in its shares on the Stock Exchange from 9:00 a.m. on November 16, 2026.